Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Telios Pharma, Inc.
Scientific Title
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of TL-895 Combined With KRT-232 in Patients With Relapsed/Refractory (R/R) FLT3+ Acute Myeloid Leukemia (AML)